Heparin-induced thrombocytopenia: an update

Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized. In this review, we briefly discuss the main features of heparin-induced thrombocytopenia,...

Descripción completa

Detalles Bibliográficos
Autor principal: Franchini, Massimo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1262784/
https://www.ncbi.nlm.nih.gov/pubmed/16202170
http://dx.doi.org/10.1186/1477-9560-3-14
_version_ 1782125914610466816
author Franchini, Massimo
author_facet Franchini, Massimo
author_sort Franchini, Massimo
collection PubMed
description Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized. In this review, we briefly discuss the main features of heparin-induced thrombocytopenia, particularly analyzing the most recent advances in the pathophysiology, diagnosis and treatment of this syndrome.
format Text
id pubmed-1262784
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12627842005-10-23 Heparin-induced thrombocytopenia: an update Franchini, Massimo Thromb J Review Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized. In this review, we briefly discuss the main features of heparin-induced thrombocytopenia, particularly analyzing the most recent advances in the pathophysiology, diagnosis and treatment of this syndrome. BioMed Central 2005-10-04 /pmc/articles/PMC1262784/ /pubmed/16202170 http://dx.doi.org/10.1186/1477-9560-3-14 Text en Copyright © 2005 Franchini; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Franchini, Massimo
Heparin-induced thrombocytopenia: an update
title Heparin-induced thrombocytopenia: an update
title_full Heparin-induced thrombocytopenia: an update
title_fullStr Heparin-induced thrombocytopenia: an update
title_full_unstemmed Heparin-induced thrombocytopenia: an update
title_short Heparin-induced thrombocytopenia: an update
title_sort heparin-induced thrombocytopenia: an update
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1262784/
https://www.ncbi.nlm.nih.gov/pubmed/16202170
http://dx.doi.org/10.1186/1477-9560-3-14
work_keys_str_mv AT franchinimassimo heparininducedthrombocytopeniaanupdate

Ejemplares similares